Education
About Us
Working with TipRanks
Follow Us
OptiBiotix Health PLC (GB:OPTI)
LSE:OPTI
OPTI Stock Chart & Stats
6.75p
0.00p(0.00%)
At close: 4:00 PM EST
6.75p
0.00p(0.00%)
Day’s Range― - ―
52-Week Range5.63p - 21.00p
Previous CloseN/A
Volume20.25K
Average Volume (3M)268.80K
Market Cap
£6.51M
Enterprise Value5.21M
Total Cash (Recent Filing)£1.30M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.95
Next Earnings
Jun 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding103,300,300
10 Day Avg. Volume266,472
30 Day Avg. Volume268,800
Financial Highlights & Ratios
PEG Ratio0.53
Price to Book (P/B)2.10
Price to Sales (P/S)20.26
P/FCF Ratio-9.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth AccelerationSustained double-digit revenue acceleration indicates improving commercial traction and product adoption by partners. Over 2–6 months this supports scalability: higher revenues can spread fixed R&D and SG&A, improving the path to operating leverage if growth is sustained and order repeatability continues.
Debt-free Balance SheetNo debt provides meaningful financial flexibility for a loss-making biotech: it reduces insolvency risk, lowers mandatory cash outflows, and allows management to prioritise commercialization and R&D. This strengthens the company's ability to fund operations or negotiate strategic partnerships without covenant pressure.
Healthy Product-level Gross MarginsA ~38% gross margin in 2024 shows the underlying ingredient business can be economically attractive at the unit level. For a B2B ingredient supplier, durable gross margins support profitable scaling as sales volumes rise and enable reinvestment in formulation, regulatory work and commercial support to drive longer-term margin expansion.
Bears Say
Persistent Negative Cash FlowConsistent operating and free cash outflows imply the business is not yet self-funding. Over months this necessitates external funding or equity dilution, constrains marketing and commercial scale-up, and increases execution risk if new financing is delayed or terms are unfavourable.
Deep And Worsening Net LossesA net margin around -207% shows current revenue does not cover operating costs and undermines return on capital. Persistently large losses erode equity, limit reinvestment capacity, and mean profitability depends on sustained high growth and meaningful cost control, elevating long-term execution risk.
Revenue Dependence On Partners And External LaunchesA partner-led B2B model concentrates revenue timing and control with third parties: product launches, marketing, and distribution are outside the company’s direct control. This structure increases variability of orders and makes sustainable growth contingent on partners' execution and renewals over multiple quarters.
OptiBiotix Health News
OPTI FAQ
What was OptiBiotix Health PLC’s price range in the past 12 months?
OptiBiotix Health PLC lowest share price was 5.63p and its highest was 21.00p in the past 12 months.
What is OptiBiotix Health PLC’s market cap?
OptiBiotix Health PLC’s market cap is £6.51M.
When is OptiBiotix Health PLC’s upcoming earnings report date?
OptiBiotix Health PLC’s upcoming earnings report date is Jun 25, 2026 which is in 128 days.
How were OptiBiotix Health PLC’s earnings last quarter?
Currently, no data Available
Is OptiBiotix Health PLC overvalued?
According to Wall Street analysts OptiBiotix Health PLC’s price is currently Overvalued.
Does OptiBiotix Health PLC pay dividends?
OptiBiotix Health PLC does not currently pay dividends.
What is OptiBiotix Health PLC’s EPS estimate?
OptiBiotix Health PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does OptiBiotix Health PLC have?
OptiBiotix Health PLC has 103,300,300 shares outstanding.
What happened to OptiBiotix Health PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of OptiBiotix Health PLC?
Currently, no hedge funds are holding shares in GB:OPTI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
OptiBiotix Health PLC
OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia and lipid profiles, and diabetes. OptiBiotix Health Plc was founded in 2012 and is headquartered in York, the United Kingdom.
Technical Analysis
Evgen Pharma
―
Futura Medical
―
Nuformix Plc
―
Cizzle Biotechnology Holdings PLC
―
SkinBioTherapeutics
―
Options Prices
Currently, No data available
---